NCT04074889View on ClinicalTrials.gov

The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver

NAUnknownINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 30, 2019

Primary Completion Date

July 31, 2020

Study Completion Date

December 31, 2020

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

(Microbial cell preparation) Probiotics

Lactobacillus acidophilus (107mg), Lactobacillus casei subsp (107mg), Lactobacillus lactis (107mg), Bifidobacterium bifidum (107mg), Bifidobacterium infantis (107mg) and Bifidobacterium longum (107mg)

OTHER

Placebo

Placebo sachet with no microbial cell preparation

Trial Locations (1)

56000

RECRUITING

The University of Malaysia Medical Centre, Cheras

Sponsors

Collaborators (1)

Fibronostics Pte. Ltd
All Listed Sponsors
collaborator

B-Crobes Laboratory Sdn. Bhd

UNKNOWN

collaborator

Fibronostics Pte. Ltd

UNKNOWN

collaborator

Ministry of Education, Malaysia

OTHER_GOV

lead

Universiti Kebangsaan Malaysia Medical Centre

OTHER